Full Press Release Details
REGENERON ANNOUNCES OFFERING OF CONVERTIBLE SENIOR SUBORDINATED NOTES IN A 144A OFFERING.
REGN
REGENERON ANNOUNCES OFFERING OF CONVERTIBLE SENIOR SUBORDINATED NOTES IN A 144A OFFERING
Key Takeaway: REGENERON ANNOUNCES OFFERING OF CONVERTIBLE SENIOR SUBORDINATED NOTES IN A 144A OFFERING
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+35%
120-day peak, hindsight
Typical move
2.6%
average across 15 past catalysts
Lead asset
VEGF Trap-Eye
Phase 1 · Diabetic Macular Edema